These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7061860)

  • 41. Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis.
    Merriam LT; Webster C; Joehl RJ
    J Surg Res; 1997 Jan; 67(1):40-5. PubMed ID: 9070179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biologically active peptides derived from the fifth component of complement.
    Goldstein IM; Perez HD
    Prog Hemost Thromb; 1980; 5():41-79. PubMed ID: 6999532
    [No Abstract]   [Full Text] [Related]  

  • 43. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
    Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
    Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies.
    Marzari R; Sblattero D; Macor P; Fischetti F; Gennaro R; Marks JD; Bradbury A; Tedesco F
    Eur J Immunol; 2002 Oct; 32(10):2773-82. PubMed ID: 12355429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The case for complement component 5 as a target in neurodegenerative disease.
    Stennett A; Friston K; Harris CL; Wollman AJM; Bronowska AK; Madden KS
    Expert Opin Ther Targets; 2023 Feb; 27(2):97-109. PubMed ID: 36786123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of C5a in the absence of C3: a new complement activation pathway.
    Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
    Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical significance of the fifth component of complement analysis].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():659-61. PubMed ID: 2355590
    [No Abstract]   [Full Text] [Related]  

  • 48. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5.
    Ramu P; Tanskanen R; Holmberg M; Lähteenmäki K; Korhonen TK; Meri S
    FEBS Lett; 2007 May; 581(9):1716-20. PubMed ID: 17418141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison.
    Vogt W; Hesse D
    Immunobiology; 1992 Apr; 184(4-5):384-91. PubMed ID: 1592429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation and characterization of the third and fifth components of rabbit complement.
    Giclas PC; Keeling PJ; Henson PM
    Mol Immunol; 1981 Feb; 18(2):113-23. PubMed ID: 7266481
    [No Abstract]   [Full Text] [Related]  

  • 52. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
    Strunk RC; Giclas PC
    J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
    [No Abstract]   [Full Text] [Related]  

  • 53. Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.
    Law SK; Lichtenberg NA; Holcombe FH; Levine RP
    J Immunol; 1980 Aug; 125(2):634-9. PubMed ID: 7391573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
    Lachmann PJ; Müller-Eberhard HJ
    J Immunol; 1968 Apr; 100(4):691-8. PubMed ID: 5645214
    [No Abstract]   [Full Text] [Related]  

  • 55. Component deficiencies. 5. The fifth component.
    McCarty GA; Snyderman R
    Prog Allergy; 1986; 39():271-82. PubMed ID: 3562467
    [No Abstract]   [Full Text] [Related]  

  • 56. Complement activation by rat platelets: its significance to inflammation in the rat.
    Walker JR
    Int Arch Allergy Appl Immunol; 1979; 60(1):44-9. PubMed ID: 457297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation and degradation of the complement fragment C5a in human serum by Bacteroides gingivalis.
    Sundqvist G; Bengtson A; Carlsson J
    Oral Microbiol Immunol; 1988 Sep; 3(3):103-7. PubMed ID: 3269992
    [No Abstract]   [Full Text] [Related]  

  • 58. [The fifth component of complement, C5].
    Takemura S
    Nihon Rinsho; 1999 Nov; 57 Suppl():68-70. PubMed ID: 10635777
    [No Abstract]   [Full Text] [Related]  

  • 59. The interleukin hypothesis: a quantitative assessment.
    Colton CK
    Kidney Int Suppl; 1988 Mar; 24():S27-9. PubMed ID: 3258938
    [No Abstract]   [Full Text] [Related]  

  • 60. Overexpression of complement C5 in endometriosis.
    Aslan C; Ak H; Askar N; Ozkaya AB; Ergenoglu AM; Yeniel AO; Akdemir A; Aydin HH
    Clin Biochem; 2014 Apr; 47(6):496-8. PubMed ID: 24316322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.